Bionanotechnology News

RSS

Novavax Initiates Phase 1/2 Clinical Trial of its H7N9 Avian Influenza VLP Vaccine Candidate

Novavax, Inc., a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, today reported its financial results for the fourth quarter and year ended December 31, 2013 and announced the initiation of a Phase 1/2 clinical trial of its H7N9 avian influenza VLP vaccine candidate with its proprietary Matrix-M adjuvant.

From Novavax Inc. 11 Mar 2014

Novel Nanoscale Measurement Approaches for Cancer Research

Jason Reed, Ph.D., is a sort of research jack-of-all-trades. He has a broad base of knowledge to pull from – an undergraduate and master’s degrees in physics and a Ph.D. in physical chemistry. While in his doctoral program, he focused on genome analysis of single DNA molecules. Since then, he has focused his research on biological systems – applying imaging approaches that look at how cancer cells grow or how they respond to treatment.

10 Mar 2014

HDL Nanotherapy Directly Targets and Lowers Dangerous Inflammation in Blood Vessels

Nanoparticles designed for drug delivery run the gamut from very artificial components like gold or specially designed RNA to particles that adapt or mimic naturally occurring nanoparticles. A noteworthy example of the latter is adapting biology’s “good cholesterol”, the high-density lipoprotein particle, to deliver anti-inflammatory drugs to prevent recurrent heart attacks and strokes.

6 Mar 2014

Simple Mathematical Way to Consider Correlations in Analysis of Cytoskeletons

Rice University researchers have developed a theoretical approach to analyze the process by which protein building blocks form the biopolymer skeletons of living cells.

6 Mar 2014

Study Investigates How Individual S. aureus Cells Glom onto Metallic Nanostructures

The bacterium Staphylococcus Aureus (S. aureus) is a common source of infections that occur after surgeries involving prosthetic joints and artificial heart valves. The grape-shaped microorganism adheres to medical equipment, and if it gets inside the body, it can cause a serious and even life-threatening illness called a Staph infection. The recent discovery of drug-resistant strains of S. aureus makes matters even worse.

From Lawrence Berkeley National Laboratory 6 Mar 2014

JEC Europe 2014: NanoCelluComp Highlights Novel Nanocellulose-Based Composites

Society relies heavily on advanced materials, such as composites, made from non-renewable petroleum-based products that are energy intensive and require significant use of volatile solvents to manufacture.

5 Mar 2014

Researchers Test Four Iron-Oxide Nanoparticle Systems for Targeting Cancer Cells

In current research related to improving cancer treatments, one promising area of research is the effort to find ways to selectively pinpoint and target cancer cells while minimizing effects on healthy cells.

4 Mar 2014

Nanomechanical Sensor Accurately Measures Cellular Stress

A new methodology for rapidly measuring the level of antibiotic drug molecules in human blood serum has been developed, paving the way to applications within drug development and personalised medicine.

4 Mar 2014

New Report Analyses International Biochip/Microarray Markets

Research and Markets has announced the addition of a new report "Concise Analysis of the International Biochips and Microarrays Market" to their offering.

From Research and Markets 28 Feb 2014

Rainbow Coral to Extend Investment Position in Nano3D Biosciences

With analysts around the globe predicting incredible growth in the 3D printing sector in the coming years, Rainbow Coral Corp. announced today that it will extend its investment position in Nano3D Biosciences (n3D), a company on the cutting edge of the 3D bioprinting revolution.

28 Feb 2014